Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.

Also called NCT01850160

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 124 participants (enrolled count) (from the registry)
Sponsor
Farma de Colombia SA (from the registry)
Registry
  • NCT NCT01850160
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Colombia, Ecuador (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01850160. Randomized; no masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2015-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy/Safety Study of Valsartan and Chlorthalidone Conjugate Treatment Compared to Simple Treatment for Hypertension
Condition
Hypertension
Intervention (Drug)
GROUP A: Valsartan plus Chlorthalidone
Intervention (Drug)
GROUP B: Valsartan
Intervention (Drug)
GROUP C: Chlorthalidone
Lead sponsor
Farma de Colombia SA (class: industry)

Record details

Record id
cardio:ct-nct01850160
Content hash
c3197e05f942e6891c67887c7960a68b2845e42c3ecd278c08e858fd79492540